ARCHIVES

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

Wilmot Researchers Study Combination for Lymphoma

September 26, 2003

ImClone: Waksals To Pay $5 Million To Settle With SEC.

January 28, 2005

In Brief: Mihich, Kennedy, Aust New Presidents; Loeb, Coltman, Cady Presidents Elect; Carbone Honored

May 29, 1987

Cancer Death Rates Declined 2.1 Percent Per Year.

October 19, 2007

In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect

April 26, 1996

Sandra Horning elected ASCO president-elect.

February 27, 2004